CIK 0000908259
- Non-accelerated filer
- Smaller reporting company
Oncotelic Therapeutics, Inc.
Sign in to watch- Ticker
- OTLC
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 133679168
- Phone
- +1 650-635-7000
- Business address
- 29397 AGOURA RD., #107, AGUORA HILLS, CA, 91301
- Former names
- MATEON THERAPEUTICS INC, OXIGENE INC
- Open-market buys, last 90 days
- $23,537
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$23,537. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-06-20 | CHAPLIN DAVID Director | Grant or award · Stock Option (Right to Buy) | +258,171 | 258,171 | ||
| 2017-01-12 | CHAPLIN DAVID Chief Scientific Officer | Grant or award · Employee Stock Option (Right to Buy) | +262,500 | $0.38 | $98K | 262,500 |
| 2016-03-21 | CHAPLIN DAVID Chief Scientific Officer | Grant or award · Employee Stock Option (Right to Buy) | +262,500 | 262,500 | ||
| 2015-05-28 | CHAPLIN DAVID Chief Scientific Officer | Grant or award · Employee Stock Option (Right to Buy) | +225,000 | 225,000 | ||
| 2014-05-15 | CHAPLIN DAVID President and CEO | Grant or award · Employee Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2014-01-02 | CHAPLIN DAVID Director | Grant or award · Stock Option (Right to Buy) | +4,880 | 4,880 | ||
| 2013-07-01 | CHAPLIN DAVID Director | Grant or award · Stock Option (Right to Buy) | +10,060 | 10,060 | ||
| 2013-01-23 | CHAPLIN DAVID Director | Grant or award · Stock Option (Right to Buy) | +6,260 | 6,260 | ||
| 2010-09-15 | CHAPLIN DAVID Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2010-04-27 | CHAPLIN DAVID Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +400,000 | 400,000 | ||
| 2009-01-20 | CHAPLIN DAVID Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +120,000 | 120,000 | ||
| 2007-01-25 | CHAPLIN DAVID Chief Scientific Officer | Grant or award · Option to Purchase Common Stock | +25,000 | 25,000 | ||
| 2005-10-03 | CHAPLIN DAVID Chief Scientific Officer | Grant or award | +80,000 | 131,100 | ||
| 2005-07-15 | CHAPLIN DAVID Chief Scientific Officer | Grant or award | +80,000 | 131,100 | ||
| 2004-07-28 | CHAPLIN DAVID Chief Scientific Officer | Grant or award · Options to purchase Common Stock | +50,000 | 50,000 | ||
| 2004-05-21 | CHAPLIN DAVID Chief Scientific Officer | Purchase | +200 | $7.47 | $1K | 200 |
| 2004-05-21 | CHAPLIN DAVID Chief Scientific Officer | Purchase | +1,500 | $7.46 | $11K | 1,700 |
| 2004-05-21 | CHAPLIN DAVID Chief Scientific Officer | Purchase | +200 | $7.45 | $1K | 1,900 |
| 2004-05-21 | CHAPLIN DAVID Chief Scientific Officer | Purchase | +100 | $7.38 | $738 | 2,000 |
Page 1 of 1 · 19 trades